Related Experiment Video

Updated: Aug 6, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

Roles of K+ channels in regulating tumour cell proliferation and apoptosis

Zhiguo Wang1

  • 1Research Centre, Montreal Heart Institute, 5000 Belanger East, Montreal, PQ H1T 1C8, Canada. wangz@icm.umontreal.ca

Pflugers Archiv : European Journal of Physiology
|March 30, 2004
PubMed

Insights

Potassium (K+) channels in cancer cells regulate cell growth and death. Targeting these channels offers potential for novel cancer therapies and diagnostic biomarkers.

Area of Science:

  • Ion channel research
  • Cancer biology
  • Molecular pharmacology

Background:

  • Potassium (K+) channels are diverse ion channels present in cell membranes.
  • These channels are found in various cell types, including cancer cells.
  • K+ channels play critical roles in regulating fundamental cellular processes like proliferation and apoptosis.

Purpose of the Study:

  • To provide a comprehensive overview of K+ channels in tumor cells.
  • To focus on the roles of K+ channels in tumor cell proliferation and apoptosis.
  • To discuss the mechanisms underlying K+ channel influence on tumor cell growth and death.

Main Methods:

  • Literature review of current research on K+ channels in tumor cells.
  • Analysis of studies investigating the function of K+ channels in cancer.
  • Discussion of potential therapeutic and diagnostic implications.

Main Results:

  • Tumor cells exhibit various types of K+ channels.
  • K+ channels significantly influence tumor cell proliferation, promoting uncontrolled growth.
  • K+ channels also play a role in inducing apoptosis (programmed cell death) in tumor cells.

Conclusions:

  • K+ channels are critical regulators of tumor cell proliferation and apoptosis.
  • These channels represent promising pharmacological targets for cancer treatment.
  • K+ channels may serve as biomarkers for cancer diagnosis and prognosis.

More Related Videos

Screening Ion Channels in Cancer Cells06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...